Loading...
Loading...
Indian Pharmaceutical Exporter Β· #7 for Cyclosporine Β· $256.4K export value Β· DGFT Verified
Chandra Bhagat Pharma Private Limited is the #7 Indian exporter of Cyclosporine with $256.4K in export value and 10 verified shipments. Chandra Bhagat Pharma Private Limited holds a 2.1% market share in Cyclosporine exports across 1 countries. The company exports 3 pharmaceutical products worth $1.8M across 3 therapeutic categories.

| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.2M | 66 | 34.1% |
| TURKEY | $2.2M | 44 | 23.1% |
| UNITED ARAB EMIRATES | $992.0K | 226 | 10.4% |
| SAUDI ARABIA | $581.3K | 24 | 6.1% |
| ECUADOR | $500.0K | 10 | 5.2% |
| MAURITIUS | $365.3K | 406 | 3.8% |
| SRI LANKA | $299.8K | 35 | 3.1% |
| JORDAN | $283.8K | 12 | 3.0% |
| YEMEN | $262.3K | 20 | 2.8% |
| QATAR | $162.6K | 27 | 1.7% |
India exports Cyclosporine to 100 countries. The top destination is UNITED STATES (34.1%), followed by TURKEY and UNITED ARAB EMIRATES.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AVET PHARMACCEUTICALS INC., | UNITED STATES | $1.6M | 32 |
| AVET PHARMACCEUTICALS INC | UNITED STATES | $900.0K | 18 |
| PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED | TURKEY | $700.0K | 14 |
| AVET PHARMACCEUTICALS INC. | UNITED STATES | $348.5K | 10 |
| M/S ARABIAN OASIS COMPANY |
India exported $8.1M worth of Cyclosporine through 2,531 shipments from 177 suppliers to 100 countries, serving 319 buyers globally. Chandra Bhagat Pharma Private Limited contributes $256.4K to this total, accounting for 2.1% of India's Cyclosporine exports.
Chandra Bhagat Pharma Private Limited's average Cyclosporine shipment value is $25.6K per consignment, based on 10 shipments totaling $256.4K.
Chandra Bhagat Pharma Private Limited ranks #7 among 177 Indian Cyclosporine exporters with a 2.1% market share. The top 3 exporters are STRIDES PHARMA SCIENCE LIMITED ($3.1M), PANACEA BIOTEC PHARMA LIMITED ($1.7M), CONCORD BIOTECH LIMITED ($700.0K). Chandra Bhagat Pharma Private Limited processed 10 shipments to 1 destination countries.
What Chandra Bhagat Pharma Private Limited must comply with to export Cyclosporine to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10β18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MODERN DRUG HOUSE | $484.4K | 29 | 2 | $16.7K |
| 6 | GENETEC LIFESCIENCES | $309.9K | 20 | 2 | $15.5K |
| 7 | CHANDRA BHAGAT PHARMA PRIVATE LIMITED β | $256.4K | 10 | 1 | $25.6K |
| 8 | RPG LIFE SCIENCES LIMITED | $252.0K | 14 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 808 | 31.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 436 | 17.2% |
| DELHI AIR CARGO ACC (INDEL4) | 290 | 11.5% |
| DELHI AIR | 219 | 8.7% |
| Bombay Air | 172 | 6.8% |
| Bombay Air Cargo | 61 | 2.4% |
| Delhi Air | 57 | 2.3% |
| CHENNAI AIR | 52 | 2.1% |
Chandra Bhagat Pharma Private Limited exports 3 products worth $1.8M. Beyond Cyclosporine, top products include Salbutamol, Amikacin. View the complete Chandra Bhagat Pharma Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cyclosporine β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Chandra Bhagat Pharma Private Limited's Cyclosporine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Chandra Bhagat Pharma Private Limited
Full Company Profile β
3 products Β· $1.8M total trade Β· 3 categories
| SAUDI ARABIA |
| $335.6K |
| 13 |
| REPUBLIC OF YEMEN CLIENT CODE | YEMEN | $280.9K | 16 |
| REGENCY PHARMA LIMITED | MAURITIUS | $276.0K | 320 |
| REPUBLIC OF YEMEN CLIENT CODE 02 | YEMEN | $203.5K | 13 |
| ARABIAN OASIS COMPANY | SAUDI ARABIA | $157.3K | 5 |
| FHC-FARMACEUTICA S A | PORTUGAL | $138.4K | 3 |
India's Cyclosporine is purchased by 319 buyers worldwide. The top buyer is AVET PHARMACCEUTICALS INC., (UNITED STATES), followed by AVET PHARMACCEUTICALS INC and PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED.
| 2 |
| $18.0K |
| 9 | OLIVE HEALTH CARE | $198.6K | 7 | 1 | $28.4K |
Chandra Bhagat Pharma Private Limited ranks #7 among 177 Indian Cyclosporine exporters. Average shipment value of $25.6K compared to the market average of $45.7K. The closest competitors by value are MODERN DRUG HOUSE and GENETEC LIFESCIENCES.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 319+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Chandra Bhagat Pharma Private Limited.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclosporine. For current shipment-level data, contact TransData Nexus.